Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend is payable on April 15, 2014 to holders of record of Series B stock at the close of business on April 1, 2014.
Such payment will cover the amount of all dividends accrued from January 1, 2014 through March 31, 2014.
Alere announces two transactions to further strengthen its core business strategy